Basic physical parameters of red clay. by Hongqi Wang (2208238)

Subjects:

BP neural network structure diagram. by Hongqi Wang (2208238)

Subjects:

Structure diagram of GBDT model. by Hongqi Wang (2208238)

Subjects:

Model prediction error analysis index. by Hongqi Wang (2208238)

Subjects:

Fitting curve parameter table. by Hongqi Wang (2208238)

Subjects:

Model prediction error analysis. by Hongqi Wang (2208238)

Subjects:

Effect of sample size on reproducibility. by Jan Willem Koten (17743224)

Subjects:

S1 Data - by Jan Willem Koten (17743224)

Subjects:

Connectivity statistics. by Jan Willem Koten (17743224)

Subjects:

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Subjects:

Effect of corrections on connectivity maps. by Jan Willem Koten (17743224)

Subjects:

(A) Thermocouple positions for the MIPS and MONO systems. (B) Preparation of bone cubes from fresh cow tibias further employed for ex vivo mechanical evaluation, osteotomy and bone... by Marsel Ganeyev (21453399)

Subjects:

Overview of selected datasets. by Tejaswini Baral (14320736)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

The sequences of si-RNAs used in this study. by Changji Li (4806930)

Subjects: